These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
17. Non-Lethal Doses of RSL3 Impair Microvascular Endothelial Barrier through Degradation of Sphingosie-1-Phosphate Receptor 1 and Cytoskeletal Arrangement in A Ferroptosis-Independent Manner. Baoyinna B; Miao J; Oliver PJ; Ye Q; Shaheen N; Kalin T; He J; Parinandi NL; Zhao Y; Zhao J Biomedicines; 2023 Sep; 11(9):. PubMed ID: 37760892 [TBL] [Abstract][Full Text] [Related]
18. S1PR1 serves as a viable drug target against pulmonary fibrosis by increasing the integrity of the endothelial barrier of the lung. Hao M; Fu R; Tai J; Tian Z; Yuan X; Chen Y; Wang M; Jiang H; Ji M; Lai F; Xue N; Bai L; Zhu Y; Lv X; Chen X; Jin J Acta Pharm Sin B; 2023 Mar; 13(3):1110-1127. PubMed ID: 36970190 [TBL] [Abstract][Full Text] [Related]
19. KLF2 exerts antifibrotic and vasoprotective effects in cirrhotic rat livers: behind the molecular mechanisms of statins. Marrone G; Maeso-Díaz R; García-Cardena G; Abraldes JG; García-Pagán JC; Bosch J; Gracia-Sancho J Gut; 2015 Sep; 64(9):1434-43. PubMed ID: 25500203 [TBL] [Abstract][Full Text] [Related]
20. Effect of simvastatin on Kruppel-like factor2, endothelial nitric oxide synthase and thrombomodulin expression in endothelial cells under shear stress. Rossi J; Rouleau L; Tardif JC; Leask RL Life Sci; 2010 Jul; 87(3-4):92-9. PubMed ID: 20493886 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]